Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/health-ministry-against-task-force-proposal-to-hike-prices-of-vital-drugs-sushmi-dey-4677069/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/health-ministry-against-task-force-proposal-to-hike-prices-of-vital-drugs-sushmi-dey-4677069/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/health-ministry-against-task-force-proposal-to-hike-prices-of-vital-drugs-sushmi-dey-4677069/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/health-ministry-against-task-force-proposal-to-hike-prices-of-vital-drugs-sushmi-dey-4677069/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f332da62630-trace').style.display = (document.getElementById('cakeErr67f332da62630-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f332da62630-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f332da62630-code').style.display = (document.getElementById('cakeErr67f332da62630-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f332da62630-context').style.display = (document.getElementById('cakeErr67f332da62630-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f332da62630-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f332da62630-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 29015,
		&#039;title&#039; =&gt; &#039;Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;There is a need to review the implementation of DPCO (Drugs Price Control Order), 2013 to resolve the genuine practical problems of implementation. The government may implement predictable and stable price control mechanisms through consultative approach with the industry,&amp;quot; the taskforce is learnt to have said in its recommendations submitted recently to the health ministry and various government departments including department of pharmaceuticals.&lt;br /&gt;
&lt;br /&gt;
However, the health ministry is against the revision of the existing price regulation. Though the ministry is yet to evaluate the task force&#039;s recommendations, officials in the ministry said it is unlikely to accept such suggestions. The health ministry, which has always maintained a stand in favour of a stricter price control regime, has also recently set up a separate committee to evaluate the impact of the current price mechanism.&lt;br /&gt;
&lt;br /&gt;
Top sources in BJP as well as many other government departments also said such recommendations would not be accepted and that there is no question of hiking prices of medicines, mainly the essential ones which are used in treatment of cancer, diabetes and cardiovascular diseases.&lt;br /&gt;
&lt;br /&gt;
The taskforce, headed by secretary to the department of pharmaceuticals, also included members from the department of industrial policy and promotion (DIPP) under the commerce ministry, Niti Aayog and department of science and technology (DST).&lt;br /&gt;
&lt;br /&gt;
According to an official source, the panel suggested the government to maintain a balance between affordability of medicines and business viability. &amp;quot;It has also pointed out that over regulation of medicine prices may act as a deterrent for pharmaceutical companies to put in more investment in India and may go against the government&#039;s approach to promote foreign investment,&amp;quot; the official said.&lt;br /&gt;
&lt;br /&gt;
The recommendations assume significance coming as they do in the wake of a recent report tabled by the pharmaceutical industry highlighting the impact of price control on availability of essential medicines and new drug launches. The industry claimed there is a slowdown in both because of a flawed implementation of the pricing policy by the regulator -National Pharmaceutical Pricing Authority (NPPA).&lt;br /&gt;
&lt;br /&gt;
The drug pricing policy, approved by the UPA government in 2012, listed 348 essential medicines - prices of which were to be capped at the average of all medicines in a particular therapeutic segment with minimum of 1% market share.&lt;br /&gt;
&lt;br /&gt;
However, in 2013, when NPPA started implementing the policy, it triggered a lot of resentment among drug manufacturers. Companies complained that the regulator had implemented the policy beyond its purview and included medicines outside the scope of the policy. The industry said NPPA&#039;s move brought in uncertainty for them, thereby delaying new launches.&lt;br /&gt;
&lt;br /&gt;
However, the regulator has so far maintained that price regulation is done as per DPCO, 2013 and that there was a huge disparity in prices of similar medicines available in the market under different brands, sometimes from the same manufacturer. According to NPPA, the existing price regulation attempts to address this issue. &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 26 August, 2015, http://timesofindia.indiatimes.com/india/Health-ministry-against-task-force-proposal-to-hike-prices-of-vital-drugs/articleshow/48675930.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;health-ministry-against-task-force-proposal-to-hike-prices-of-vital-drugs-sushmi-dey-4677069&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4677069,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 29015,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;National Pharmaceutical Pricing Authority (NPPA),Access to Health,Access to Healthcare,Access to Medicines,medicine,Medicine Prices&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India

NEW DELHI: A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control,...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics.&lt;br /&gt;&lt;br /&gt;&amp;quot;There is a need to review the implementation of DPCO (Drugs Price Control Order), 2013 to resolve the genuine practical problems of implementation. The government may implement predictable and stable price control mechanisms through consultative approach with the industry,&amp;quot; the taskforce is learnt to have said in its recommendations submitted recently to the health ministry and various government departments including department of pharmaceuticals.&lt;br /&gt;&lt;br /&gt;However, the health ministry is against the revision of the existing price regulation. Though the ministry is yet to evaluate the task force&#039;s recommendations, officials in the ministry said it is unlikely to accept such suggestions. The health ministry, which has always maintained a stand in favour of a stricter price control regime, has also recently set up a separate committee to evaluate the impact of the current price mechanism.&lt;br /&gt;&lt;br /&gt;Top sources in BJP as well as many other government departments also said such recommendations would not be accepted and that there is no question of hiking prices of medicines, mainly the essential ones which are used in treatment of cancer, diabetes and cardiovascular diseases.&lt;br /&gt;&lt;br /&gt;The taskforce, headed by secretary to the department of pharmaceuticals, also included members from the department of industrial policy and promotion (DIPP) under the commerce ministry, Niti Aayog and department of science and technology (DST).&lt;br /&gt;&lt;br /&gt;According to an official source, the panel suggested the government to maintain a balance between affordability of medicines and business viability. &amp;quot;It has also pointed out that over regulation of medicine prices may act as a deterrent for pharmaceutical companies to put in more investment in India and may go against the government&#039;s approach to promote foreign investment,&amp;quot; the official said.&lt;br /&gt;&lt;br /&gt;The recommendations assume significance coming as they do in the wake of a recent report tabled by the pharmaceutical industry highlighting the impact of price control on availability of essential medicines and new drug launches. The industry claimed there is a slowdown in both because of a flawed implementation of the pricing policy by the regulator -National Pharmaceutical Pricing Authority (NPPA).&lt;br /&gt;&lt;br /&gt;The drug pricing policy, approved by the UPA government in 2012, listed 348 essential medicines - prices of which were to be capped at the average of all medicines in a particular therapeutic segment with minimum of 1% market share.&lt;br /&gt;&lt;br /&gt;However, in 2013, when NPPA started implementing the policy, it triggered a lot of resentment among drug manufacturers. Companies complained that the regulator had implemented the policy beyond its purview and included medicines outside the scope of the policy. The industry said NPPA&#039;s move brought in uncertainty for them, thereby delaying new launches.&lt;br /&gt;&lt;br /&gt;However, the regulator has so far maintained that price regulation is done as per DPCO, 2013 and that there was a huge disparity in prices of similar medicines available in the market under different brands, sometimes from the same manufacturer. According to NPPA, the existing price regulation attempts to address this issue. &lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 29015,
	&#039;title&#039; =&gt; &#039;Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;There is a need to review the implementation of DPCO (Drugs Price Control Order), 2013 to resolve the genuine practical problems of implementation. The government may implement predictable and stable price control mechanisms through consultative approach with the industry,&amp;quot; the taskforce is learnt to have said in its recommendations submitted recently to the health ministry and various government departments including department of pharmaceuticals.&lt;br /&gt;
&lt;br /&gt;
However, the health ministry is against the revision of the existing price regulation. Though the ministry is yet to evaluate the task force&#039;s recommendations, officials in the ministry said it is unlikely to accept such suggestions. The health ministry, which has always maintained a stand in favour of a stricter price control regime, has also recently set up a separate committee to evaluate the impact of the current price mechanism.&lt;br /&gt;
&lt;br /&gt;
Top sources in BJP as well as many other government departments also said such recommendations would not be accepted and that there is no question of hiking prices of medicines, mainly the essential ones which are used in treatment of cancer, diabetes and cardiovascular diseases.&lt;br /&gt;
&lt;br /&gt;
The taskforce, headed by secretary to the department of pharmaceuticals, also included members from the department of industrial policy and promotion (DIPP) under the commerce ministry, Niti Aayog and department of science and technology (DST).&lt;br /&gt;
&lt;br /&gt;
According to an official source, the panel suggested the government to maintain a balance between affordability of medicines and business viability. &amp;quot;It has also pointed out that over regulation of medicine prices may act as a deterrent for pharmaceutical companies to put in more investment in India and may go against the government&#039;s approach to promote foreign investment,&amp;quot; the official said.&lt;br /&gt;
&lt;br /&gt;
The recommendations assume significance coming as they do in the wake of a recent report tabled by the pharmaceutical industry highlighting the impact of price control on availability of essential medicines and new drug launches. The industry claimed there is a slowdown in both because of a flawed implementation of the pricing policy by the regulator -National Pharmaceutical Pricing Authority (NPPA).&lt;br /&gt;
&lt;br /&gt;
The drug pricing policy, approved by the UPA government in 2012, listed 348 essential medicines - prices of which were to be capped at the average of all medicines in a particular therapeutic segment with minimum of 1% market share.&lt;br /&gt;
&lt;br /&gt;
However, in 2013, when NPPA started implementing the policy, it triggered a lot of resentment among drug manufacturers. Companies complained that the regulator had implemented the policy beyond its purview and included medicines outside the scope of the policy. The industry said NPPA&#039;s move brought in uncertainty for them, thereby delaying new launches.&lt;br /&gt;
&lt;br /&gt;
However, the regulator has so far maintained that price regulation is done as per DPCO, 2013 and that there was a huge disparity in prices of similar medicines available in the market under different brands, sometimes from the same manufacturer. According to NPPA, the existing price regulation attempts to address this issue. &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 26 August, 2015, http://timesofindia.indiatimes.com/india/Health-ministry-against-task-force-proposal-to-hike-prices-of-vital-drugs/articleshow/48675930.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;health-ministry-against-task-force-proposal-to-hike-prices-of-vital-drugs-sushmi-dey-4677069&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4677069,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 29015
$metaTitle = &#039;LATEST NEWS UPDATES | Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey&#039;
$metaKeywords = &#039;National Pharmaceutical Pricing Authority (NPPA),Access to Health,Access to Healthcare,Access to Medicines,medicine,Medicine Prices&#039;
$metaDesc = &#039;
-The Times of India

NEW DELHI: A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control,...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics.&lt;br /&gt;&lt;br /&gt;&amp;quot;There is a need to review the implementation of DPCO (Drugs Price Control Order), 2013 to resolve the genuine practical problems of implementation. The government may implement predictable and stable price control mechanisms through consultative approach with the industry,&amp;quot; the taskforce is learnt to have said in its recommendations submitted recently to the health ministry and various government departments including department of pharmaceuticals.&lt;br /&gt;&lt;br /&gt;However, the health ministry is against the revision of the existing price regulation. Though the ministry is yet to evaluate the task force&#039;s recommendations, officials in the ministry said it is unlikely to accept such suggestions. The health ministry, which has always maintained a stand in favour of a stricter price control regime, has also recently set up a separate committee to evaluate the impact of the current price mechanism.&lt;br /&gt;&lt;br /&gt;Top sources in BJP as well as many other government departments also said such recommendations would not be accepted and that there is no question of hiking prices of medicines, mainly the essential ones which are used in treatment of cancer, diabetes and cardiovascular diseases.&lt;br /&gt;&lt;br /&gt;The taskforce, headed by secretary to the department of pharmaceuticals, also included members from the department of industrial policy and promotion (DIPP) under the commerce ministry, Niti Aayog and department of science and technology (DST).&lt;br /&gt;&lt;br /&gt;According to an official source, the panel suggested the government to maintain a balance between affordability of medicines and business viability. &amp;quot;It has also pointed out that over regulation of medicine prices may act as a deterrent for pharmaceutical companies to put in more investment in India and may go against the government&#039;s approach to promote foreign investment,&amp;quot; the official said.&lt;br /&gt;&lt;br /&gt;The recommendations assume significance coming as they do in the wake of a recent report tabled by the pharmaceutical industry highlighting the impact of price control on availability of essential medicines and new drug launches. The industry claimed there is a slowdown in both because of a flawed implementation of the pricing policy by the regulator -National Pharmaceutical Pricing Authority (NPPA).&lt;br /&gt;&lt;br /&gt;The drug pricing policy, approved by the UPA government in 2012, listed 348 essential medicines - prices of which were to be capped at the average of all medicines in a particular therapeutic segment with minimum of 1% market share.&lt;br /&gt;&lt;br /&gt;However, in 2013, when NPPA started implementing the policy, it triggered a lot of resentment among drug manufacturers. Companies complained that the regulator had implemented the policy beyond its purview and included medicines outside the scope of the policy. The industry said NPPA&#039;s move brought in uncertainty for them, thereby delaying new launches.&lt;br /&gt;&lt;br /&gt;However, the regulator has so far maintained that price regulation is done as per DPCO, 2013 and that there was a huge disparity in prices of similar medicines available in the market under different brands, sometimes from the same manufacturer. According to NPPA, the existing price regulation attempts to address this issue. &lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/health-ministry-against-task-force-proposal-to-hike-prices-of-vital-drugs-sushmi-dey-4677069.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Times of India

NEW DELHI: A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control,..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India<br /><br /><em>NEW DELHI: </em>A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics.<br /><br />&quot;There is a need to review the implementation of DPCO (Drugs Price Control Order), 2013 to resolve the genuine practical problems of implementation. The government may implement predictable and stable price control mechanisms through consultative approach with the industry,&quot; the taskforce is learnt to have said in its recommendations submitted recently to the health ministry and various government departments including department of pharmaceuticals.<br /><br />However, the health ministry is against the revision of the existing price regulation. Though the ministry is yet to evaluate the task force's recommendations, officials in the ministry said it is unlikely to accept such suggestions. The health ministry, which has always maintained a stand in favour of a stricter price control regime, has also recently set up a separate committee to evaluate the impact of the current price mechanism.<br /><br />Top sources in BJP as well as many other government departments also said such recommendations would not be accepted and that there is no question of hiking prices of medicines, mainly the essential ones which are used in treatment of cancer, diabetes and cardiovascular diseases.<br /><br />The taskforce, headed by secretary to the department of pharmaceuticals, also included members from the department of industrial policy and promotion (DIPP) under the commerce ministry, Niti Aayog and department of science and technology (DST).<br /><br />According to an official source, the panel suggested the government to maintain a balance between affordability of medicines and business viability. &quot;It has also pointed out that over regulation of medicine prices may act as a deterrent for pharmaceutical companies to put in more investment in India and may go against the government's approach to promote foreign investment,&quot; the official said.<br /><br />The recommendations assume significance coming as they do in the wake of a recent report tabled by the pharmaceutical industry highlighting the impact of price control on availability of essential medicines and new drug launches. The industry claimed there is a slowdown in both because of a flawed implementation of the pricing policy by the regulator -National Pharmaceutical Pricing Authority (NPPA).<br /><br />The drug pricing policy, approved by the UPA government in 2012, listed 348 essential medicines - prices of which were to be capped at the average of all medicines in a particular therapeutic segment with minimum of 1% market share.<br /><br />However, in 2013, when NPPA started implementing the policy, it triggered a lot of resentment among drug manufacturers. Companies complained that the regulator had implemented the policy beyond its purview and included medicines outside the scope of the policy. The industry said NPPA's move brought in uncertainty for them, thereby delaying new launches.<br /><br />However, the regulator has so far maintained that price regulation is done as per DPCO, 2013 and that there was a huge disparity in prices of similar medicines available in the market under different brands, sometimes from the same manufacturer. According to NPPA, the existing price regulation attempts to address this issue. <br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f332da62630-trace').style.display = (document.getElementById('cakeErr67f332da62630-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f332da62630-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f332da62630-code').style.display = (document.getElementById('cakeErr67f332da62630-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f332da62630-context').style.display = (document.getElementById('cakeErr67f332da62630-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f332da62630-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f332da62630-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 29015,
		&#039;title&#039; =&gt; &#039;Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;There is a need to review the implementation of DPCO (Drugs Price Control Order), 2013 to resolve the genuine practical problems of implementation. The government may implement predictable and stable price control mechanisms through consultative approach with the industry,&amp;quot; the taskforce is learnt to have said in its recommendations submitted recently to the health ministry and various government departments including department of pharmaceuticals.&lt;br /&gt;
&lt;br /&gt;
However, the health ministry is against the revision of the existing price regulation. Though the ministry is yet to evaluate the task force&#039;s recommendations, officials in the ministry said it is unlikely to accept such suggestions. The health ministry, which has always maintained a stand in favour of a stricter price control regime, has also recently set up a separate committee to evaluate the impact of the current price mechanism.&lt;br /&gt;
&lt;br /&gt;
Top sources in BJP as well as many other government departments also said such recommendations would not be accepted and that there is no question of hiking prices of medicines, mainly the essential ones which are used in treatment of cancer, diabetes and cardiovascular diseases.&lt;br /&gt;
&lt;br /&gt;
The taskforce, headed by secretary to the department of pharmaceuticals, also included members from the department of industrial policy and promotion (DIPP) under the commerce ministry, Niti Aayog and department of science and technology (DST).&lt;br /&gt;
&lt;br /&gt;
According to an official source, the panel suggested the government to maintain a balance between affordability of medicines and business viability. &amp;quot;It has also pointed out that over regulation of medicine prices may act as a deterrent for pharmaceutical companies to put in more investment in India and may go against the government&#039;s approach to promote foreign investment,&amp;quot; the official said.&lt;br /&gt;
&lt;br /&gt;
The recommendations assume significance coming as they do in the wake of a recent report tabled by the pharmaceutical industry highlighting the impact of price control on availability of essential medicines and new drug launches. The industry claimed there is a slowdown in both because of a flawed implementation of the pricing policy by the regulator -National Pharmaceutical Pricing Authority (NPPA).&lt;br /&gt;
&lt;br /&gt;
The drug pricing policy, approved by the UPA government in 2012, listed 348 essential medicines - prices of which were to be capped at the average of all medicines in a particular therapeutic segment with minimum of 1% market share.&lt;br /&gt;
&lt;br /&gt;
However, in 2013, when NPPA started implementing the policy, it triggered a lot of resentment among drug manufacturers. Companies complained that the regulator had implemented the policy beyond its purview and included medicines outside the scope of the policy. The industry said NPPA&#039;s move brought in uncertainty for them, thereby delaying new launches.&lt;br /&gt;
&lt;br /&gt;
However, the regulator has so far maintained that price regulation is done as per DPCO, 2013 and that there was a huge disparity in prices of similar medicines available in the market under different brands, sometimes from the same manufacturer. According to NPPA, the existing price regulation attempts to address this issue. &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 26 August, 2015, http://timesofindia.indiatimes.com/india/Health-ministry-against-task-force-proposal-to-hike-prices-of-vital-drugs/articleshow/48675930.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;health-ministry-against-task-force-proposal-to-hike-prices-of-vital-drugs-sushmi-dey-4677069&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4677069,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 29015,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;National Pharmaceutical Pricing Authority (NPPA),Access to Health,Access to Healthcare,Access to Medicines,medicine,Medicine Prices&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India

NEW DELHI: A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control,...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics.&lt;br /&gt;&lt;br /&gt;&amp;quot;There is a need to review the implementation of DPCO (Drugs Price Control Order), 2013 to resolve the genuine practical problems of implementation. The government may implement predictable and stable price control mechanisms through consultative approach with the industry,&amp;quot; the taskforce is learnt to have said in its recommendations submitted recently to the health ministry and various government departments including department of pharmaceuticals.&lt;br /&gt;&lt;br /&gt;However, the health ministry is against the revision of the existing price regulation. Though the ministry is yet to evaluate the task force&#039;s recommendations, officials in the ministry said it is unlikely to accept such suggestions. The health ministry, which has always maintained a stand in favour of a stricter price control regime, has also recently set up a separate committee to evaluate the impact of the current price mechanism.&lt;br /&gt;&lt;br /&gt;Top sources in BJP as well as many other government departments also said such recommendations would not be accepted and that there is no question of hiking prices of medicines, mainly the essential ones which are used in treatment of cancer, diabetes and cardiovascular diseases.&lt;br /&gt;&lt;br /&gt;The taskforce, headed by secretary to the department of pharmaceuticals, also included members from the department of industrial policy and promotion (DIPP) under the commerce ministry, Niti Aayog and department of science and technology (DST).&lt;br /&gt;&lt;br /&gt;According to an official source, the panel suggested the government to maintain a balance between affordability of medicines and business viability. &amp;quot;It has also pointed out that over regulation of medicine prices may act as a deterrent for pharmaceutical companies to put in more investment in India and may go against the government&#039;s approach to promote foreign investment,&amp;quot; the official said.&lt;br /&gt;&lt;br /&gt;The recommendations assume significance coming as they do in the wake of a recent report tabled by the pharmaceutical industry highlighting the impact of price control on availability of essential medicines and new drug launches. The industry claimed there is a slowdown in both because of a flawed implementation of the pricing policy by the regulator -National Pharmaceutical Pricing Authority (NPPA).&lt;br /&gt;&lt;br /&gt;The drug pricing policy, approved by the UPA government in 2012, listed 348 essential medicines - prices of which were to be capped at the average of all medicines in a particular therapeutic segment with minimum of 1% market share.&lt;br /&gt;&lt;br /&gt;However, in 2013, when NPPA started implementing the policy, it triggered a lot of resentment among drug manufacturers. Companies complained that the regulator had implemented the policy beyond its purview and included medicines outside the scope of the policy. The industry said NPPA&#039;s move brought in uncertainty for them, thereby delaying new launches.&lt;br /&gt;&lt;br /&gt;However, the regulator has so far maintained that price regulation is done as per DPCO, 2013 and that there was a huge disparity in prices of similar medicines available in the market under different brands, sometimes from the same manufacturer. According to NPPA, the existing price regulation attempts to address this issue. &lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 29015,
	&#039;title&#039; =&gt; &#039;Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;There is a need to review the implementation of DPCO (Drugs Price Control Order), 2013 to resolve the genuine practical problems of implementation. The government may implement predictable and stable price control mechanisms through consultative approach with the industry,&amp;quot; the taskforce is learnt to have said in its recommendations submitted recently to the health ministry and various government departments including department of pharmaceuticals.&lt;br /&gt;
&lt;br /&gt;
However, the health ministry is against the revision of the existing price regulation. Though the ministry is yet to evaluate the task force&#039;s recommendations, officials in the ministry said it is unlikely to accept such suggestions. The health ministry, which has always maintained a stand in favour of a stricter price control regime, has also recently set up a separate committee to evaluate the impact of the current price mechanism.&lt;br /&gt;
&lt;br /&gt;
Top sources in BJP as well as many other government departments also said such recommendations would not be accepted and that there is no question of hiking prices of medicines, mainly the essential ones which are used in treatment of cancer, diabetes and cardiovascular diseases.&lt;br /&gt;
&lt;br /&gt;
The taskforce, headed by secretary to the department of pharmaceuticals, also included members from the department of industrial policy and promotion (DIPP) under the commerce ministry, Niti Aayog and department of science and technology (DST).&lt;br /&gt;
&lt;br /&gt;
According to an official source, the panel suggested the government to maintain a balance between affordability of medicines and business viability. &amp;quot;It has also pointed out that over regulation of medicine prices may act as a deterrent for pharmaceutical companies to put in more investment in India and may go against the government&#039;s approach to promote foreign investment,&amp;quot; the official said.&lt;br /&gt;
&lt;br /&gt;
The recommendations assume significance coming as they do in the wake of a recent report tabled by the pharmaceutical industry highlighting the impact of price control on availability of essential medicines and new drug launches. The industry claimed there is a slowdown in both because of a flawed implementation of the pricing policy by the regulator -National Pharmaceutical Pricing Authority (NPPA).&lt;br /&gt;
&lt;br /&gt;
The drug pricing policy, approved by the UPA government in 2012, listed 348 essential medicines - prices of which were to be capped at the average of all medicines in a particular therapeutic segment with minimum of 1% market share.&lt;br /&gt;
&lt;br /&gt;
However, in 2013, when NPPA started implementing the policy, it triggered a lot of resentment among drug manufacturers. Companies complained that the regulator had implemented the policy beyond its purview and included medicines outside the scope of the policy. The industry said NPPA&#039;s move brought in uncertainty for them, thereby delaying new launches.&lt;br /&gt;
&lt;br /&gt;
However, the regulator has so far maintained that price regulation is done as per DPCO, 2013 and that there was a huge disparity in prices of similar medicines available in the market under different brands, sometimes from the same manufacturer. According to NPPA, the existing price regulation attempts to address this issue. &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 26 August, 2015, http://timesofindia.indiatimes.com/india/Health-ministry-against-task-force-proposal-to-hike-prices-of-vital-drugs/articleshow/48675930.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;health-ministry-against-task-force-proposal-to-hike-prices-of-vital-drugs-sushmi-dey-4677069&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4677069,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 29015
$metaTitle = &#039;LATEST NEWS UPDATES | Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey&#039;
$metaKeywords = &#039;National Pharmaceutical Pricing Authority (NPPA),Access to Health,Access to Healthcare,Access to Medicines,medicine,Medicine Prices&#039;
$metaDesc = &#039;
-The Times of India

NEW DELHI: A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control,...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics.&lt;br /&gt;&lt;br /&gt;&amp;quot;There is a need to review the implementation of DPCO (Drugs Price Control Order), 2013 to resolve the genuine practical problems of implementation. The government may implement predictable and stable price control mechanisms through consultative approach with the industry,&amp;quot; the taskforce is learnt to have said in its recommendations submitted recently to the health ministry and various government departments including department of pharmaceuticals.&lt;br /&gt;&lt;br /&gt;However, the health ministry is against the revision of the existing price regulation. Though the ministry is yet to evaluate the task force&#039;s recommendations, officials in the ministry said it is unlikely to accept such suggestions. The health ministry, which has always maintained a stand in favour of a stricter price control regime, has also recently set up a separate committee to evaluate the impact of the current price mechanism.&lt;br /&gt;&lt;br /&gt;Top sources in BJP as well as many other government departments also said such recommendations would not be accepted and that there is no question of hiking prices of medicines, mainly the essential ones which are used in treatment of cancer, diabetes and cardiovascular diseases.&lt;br /&gt;&lt;br /&gt;The taskforce, headed by secretary to the department of pharmaceuticals, also included members from the department of industrial policy and promotion (DIPP) under the commerce ministry, Niti Aayog and department of science and technology (DST).&lt;br /&gt;&lt;br /&gt;According to an official source, the panel suggested the government to maintain a balance between affordability of medicines and business viability. &amp;quot;It has also pointed out that over regulation of medicine prices may act as a deterrent for pharmaceutical companies to put in more investment in India and may go against the government&#039;s approach to promote foreign investment,&amp;quot; the official said.&lt;br /&gt;&lt;br /&gt;The recommendations assume significance coming as they do in the wake of a recent report tabled by the pharmaceutical industry highlighting the impact of price control on availability of essential medicines and new drug launches. The industry claimed there is a slowdown in both because of a flawed implementation of the pricing policy by the regulator -National Pharmaceutical Pricing Authority (NPPA).&lt;br /&gt;&lt;br /&gt;The drug pricing policy, approved by the UPA government in 2012, listed 348 essential medicines - prices of which were to be capped at the average of all medicines in a particular therapeutic segment with minimum of 1% market share.&lt;br /&gt;&lt;br /&gt;However, in 2013, when NPPA started implementing the policy, it triggered a lot of resentment among drug manufacturers. Companies complained that the regulator had implemented the policy beyond its purview and included medicines outside the scope of the policy. The industry said NPPA&#039;s move brought in uncertainty for them, thereby delaying new launches.&lt;br /&gt;&lt;br /&gt;However, the regulator has so far maintained that price regulation is done as per DPCO, 2013 and that there was a huge disparity in prices of similar medicines available in the market under different brands, sometimes from the same manufacturer. According to NPPA, the existing price regulation attempts to address this issue. &lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/health-ministry-against-task-force-proposal-to-hike-prices-of-vital-drugs-sushmi-dey-4677069.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Times of India

NEW DELHI: A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control,..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India<br /><br /><em>NEW DELHI: </em>A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics.<br /><br />&quot;There is a need to review the implementation of DPCO (Drugs Price Control Order), 2013 to resolve the genuine practical problems of implementation. The government may implement predictable and stable price control mechanisms through consultative approach with the industry,&quot; the taskforce is learnt to have said in its recommendations submitted recently to the health ministry and various government departments including department of pharmaceuticals.<br /><br />However, the health ministry is against the revision of the existing price regulation. Though the ministry is yet to evaluate the task force's recommendations, officials in the ministry said it is unlikely to accept such suggestions. The health ministry, which has always maintained a stand in favour of a stricter price control regime, has also recently set up a separate committee to evaluate the impact of the current price mechanism.<br /><br />Top sources in BJP as well as many other government departments also said such recommendations would not be accepted and that there is no question of hiking prices of medicines, mainly the essential ones which are used in treatment of cancer, diabetes and cardiovascular diseases.<br /><br />The taskforce, headed by secretary to the department of pharmaceuticals, also included members from the department of industrial policy and promotion (DIPP) under the commerce ministry, Niti Aayog and department of science and technology (DST).<br /><br />According to an official source, the panel suggested the government to maintain a balance between affordability of medicines and business viability. &quot;It has also pointed out that over regulation of medicine prices may act as a deterrent for pharmaceutical companies to put in more investment in India and may go against the government's approach to promote foreign investment,&quot; the official said.<br /><br />The recommendations assume significance coming as they do in the wake of a recent report tabled by the pharmaceutical industry highlighting the impact of price control on availability of essential medicines and new drug launches. The industry claimed there is a slowdown in both because of a flawed implementation of the pricing policy by the regulator -National Pharmaceutical Pricing Authority (NPPA).<br /><br />The drug pricing policy, approved by the UPA government in 2012, listed 348 essential medicines - prices of which were to be capped at the average of all medicines in a particular therapeutic segment with minimum of 1% market share.<br /><br />However, in 2013, when NPPA started implementing the policy, it triggered a lot of resentment among drug manufacturers. Companies complained that the regulator had implemented the policy beyond its purview and included medicines outside the scope of the policy. The industry said NPPA's move brought in uncertainty for them, thereby delaying new launches.<br /><br />However, the regulator has so far maintained that price regulation is done as per DPCO, 2013 and that there was a huge disparity in prices of similar medicines available in the market under different brands, sometimes from the same manufacturer. According to NPPA, the existing price regulation attempts to address this issue. <br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f332da62630-trace').style.display = (document.getElementById('cakeErr67f332da62630-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f332da62630-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f332da62630-code').style.display = (document.getElementById('cakeErr67f332da62630-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f332da62630-context').style.display = (document.getElementById('cakeErr67f332da62630-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f332da62630-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f332da62630-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 29015,
		&#039;title&#039; =&gt; &#039;Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;There is a need to review the implementation of DPCO (Drugs Price Control Order), 2013 to resolve the genuine practical problems of implementation. The government may implement predictable and stable price control mechanisms through consultative approach with the industry,&amp;quot; the taskforce is learnt to have said in its recommendations submitted recently to the health ministry and various government departments including department of pharmaceuticals.&lt;br /&gt;
&lt;br /&gt;
However, the health ministry is against the revision of the existing price regulation. Though the ministry is yet to evaluate the task force&#039;s recommendations, officials in the ministry said it is unlikely to accept such suggestions. The health ministry, which has always maintained a stand in favour of a stricter price control regime, has also recently set up a separate committee to evaluate the impact of the current price mechanism.&lt;br /&gt;
&lt;br /&gt;
Top sources in BJP as well as many other government departments also said such recommendations would not be accepted and that there is no question of hiking prices of medicines, mainly the essential ones which are used in treatment of cancer, diabetes and cardiovascular diseases.&lt;br /&gt;
&lt;br /&gt;
The taskforce, headed by secretary to the department of pharmaceuticals, also included members from the department of industrial policy and promotion (DIPP) under the commerce ministry, Niti Aayog and department of science and technology (DST).&lt;br /&gt;
&lt;br /&gt;
According to an official source, the panel suggested the government to maintain a balance between affordability of medicines and business viability. &amp;quot;It has also pointed out that over regulation of medicine prices may act as a deterrent for pharmaceutical companies to put in more investment in India and may go against the government&#039;s approach to promote foreign investment,&amp;quot; the official said.&lt;br /&gt;
&lt;br /&gt;
The recommendations assume significance coming as they do in the wake of a recent report tabled by the pharmaceutical industry highlighting the impact of price control on availability of essential medicines and new drug launches. The industry claimed there is a slowdown in both because of a flawed implementation of the pricing policy by the regulator -National Pharmaceutical Pricing Authority (NPPA).&lt;br /&gt;
&lt;br /&gt;
The drug pricing policy, approved by the UPA government in 2012, listed 348 essential medicines - prices of which were to be capped at the average of all medicines in a particular therapeutic segment with minimum of 1% market share.&lt;br /&gt;
&lt;br /&gt;
However, in 2013, when NPPA started implementing the policy, it triggered a lot of resentment among drug manufacturers. Companies complained that the regulator had implemented the policy beyond its purview and included medicines outside the scope of the policy. The industry said NPPA&#039;s move brought in uncertainty for them, thereby delaying new launches.&lt;br /&gt;
&lt;br /&gt;
However, the regulator has so far maintained that price regulation is done as per DPCO, 2013 and that there was a huge disparity in prices of similar medicines available in the market under different brands, sometimes from the same manufacturer. According to NPPA, the existing price regulation attempts to address this issue. &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 26 August, 2015, http://timesofindia.indiatimes.com/india/Health-ministry-against-task-force-proposal-to-hike-prices-of-vital-drugs/articleshow/48675930.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;health-ministry-against-task-force-proposal-to-hike-prices-of-vital-drugs-sushmi-dey-4677069&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4677069,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 29015,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;National Pharmaceutical Pricing Authority (NPPA),Access to Health,Access to Healthcare,Access to Medicines,medicine,Medicine Prices&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India

NEW DELHI: A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control,...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics.&lt;br /&gt;&lt;br /&gt;&amp;quot;There is a need to review the implementation of DPCO (Drugs Price Control Order), 2013 to resolve the genuine practical problems of implementation. The government may implement predictable and stable price control mechanisms through consultative approach with the industry,&amp;quot; the taskforce is learnt to have said in its recommendations submitted recently to the health ministry and various government departments including department of pharmaceuticals.&lt;br /&gt;&lt;br /&gt;However, the health ministry is against the revision of the existing price regulation. Though the ministry is yet to evaluate the task force&#039;s recommendations, officials in the ministry said it is unlikely to accept such suggestions. The health ministry, which has always maintained a stand in favour of a stricter price control regime, has also recently set up a separate committee to evaluate the impact of the current price mechanism.&lt;br /&gt;&lt;br /&gt;Top sources in BJP as well as many other government departments also said such recommendations would not be accepted and that there is no question of hiking prices of medicines, mainly the essential ones which are used in treatment of cancer, diabetes and cardiovascular diseases.&lt;br /&gt;&lt;br /&gt;The taskforce, headed by secretary to the department of pharmaceuticals, also included members from the department of industrial policy and promotion (DIPP) under the commerce ministry, Niti Aayog and department of science and technology (DST).&lt;br /&gt;&lt;br /&gt;According to an official source, the panel suggested the government to maintain a balance between affordability of medicines and business viability. &amp;quot;It has also pointed out that over regulation of medicine prices may act as a deterrent for pharmaceutical companies to put in more investment in India and may go against the government&#039;s approach to promote foreign investment,&amp;quot; the official said.&lt;br /&gt;&lt;br /&gt;The recommendations assume significance coming as they do in the wake of a recent report tabled by the pharmaceutical industry highlighting the impact of price control on availability of essential medicines and new drug launches. The industry claimed there is a slowdown in both because of a flawed implementation of the pricing policy by the regulator -National Pharmaceutical Pricing Authority (NPPA).&lt;br /&gt;&lt;br /&gt;The drug pricing policy, approved by the UPA government in 2012, listed 348 essential medicines - prices of which were to be capped at the average of all medicines in a particular therapeutic segment with minimum of 1% market share.&lt;br /&gt;&lt;br /&gt;However, in 2013, when NPPA started implementing the policy, it triggered a lot of resentment among drug manufacturers. Companies complained that the regulator had implemented the policy beyond its purview and included medicines outside the scope of the policy. The industry said NPPA&#039;s move brought in uncertainty for them, thereby delaying new launches.&lt;br /&gt;&lt;br /&gt;However, the regulator has so far maintained that price regulation is done as per DPCO, 2013 and that there was a huge disparity in prices of similar medicines available in the market under different brands, sometimes from the same manufacturer. According to NPPA, the existing price regulation attempts to address this issue. &lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 29015,
	&#039;title&#039; =&gt; &#039;Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;There is a need to review the implementation of DPCO (Drugs Price Control Order), 2013 to resolve the genuine practical problems of implementation. The government may implement predictable and stable price control mechanisms through consultative approach with the industry,&amp;quot; the taskforce is learnt to have said in its recommendations submitted recently to the health ministry and various government departments including department of pharmaceuticals.&lt;br /&gt;
&lt;br /&gt;
However, the health ministry is against the revision of the existing price regulation. Though the ministry is yet to evaluate the task force&#039;s recommendations, officials in the ministry said it is unlikely to accept such suggestions. The health ministry, which has always maintained a stand in favour of a stricter price control regime, has also recently set up a separate committee to evaluate the impact of the current price mechanism.&lt;br /&gt;
&lt;br /&gt;
Top sources in BJP as well as many other government departments also said such recommendations would not be accepted and that there is no question of hiking prices of medicines, mainly the essential ones which are used in treatment of cancer, diabetes and cardiovascular diseases.&lt;br /&gt;
&lt;br /&gt;
The taskforce, headed by secretary to the department of pharmaceuticals, also included members from the department of industrial policy and promotion (DIPP) under the commerce ministry, Niti Aayog and department of science and technology (DST).&lt;br /&gt;
&lt;br /&gt;
According to an official source, the panel suggested the government to maintain a balance between affordability of medicines and business viability. &amp;quot;It has also pointed out that over regulation of medicine prices may act as a deterrent for pharmaceutical companies to put in more investment in India and may go against the government&#039;s approach to promote foreign investment,&amp;quot; the official said.&lt;br /&gt;
&lt;br /&gt;
The recommendations assume significance coming as they do in the wake of a recent report tabled by the pharmaceutical industry highlighting the impact of price control on availability of essential medicines and new drug launches. The industry claimed there is a slowdown in both because of a flawed implementation of the pricing policy by the regulator -National Pharmaceutical Pricing Authority (NPPA).&lt;br /&gt;
&lt;br /&gt;
The drug pricing policy, approved by the UPA government in 2012, listed 348 essential medicines - prices of which were to be capped at the average of all medicines in a particular therapeutic segment with minimum of 1% market share.&lt;br /&gt;
&lt;br /&gt;
However, in 2013, when NPPA started implementing the policy, it triggered a lot of resentment among drug manufacturers. Companies complained that the regulator had implemented the policy beyond its purview and included medicines outside the scope of the policy. The industry said NPPA&#039;s move brought in uncertainty for them, thereby delaying new launches.&lt;br /&gt;
&lt;br /&gt;
However, the regulator has so far maintained that price regulation is done as per DPCO, 2013 and that there was a huge disparity in prices of similar medicines available in the market under different brands, sometimes from the same manufacturer. According to NPPA, the existing price regulation attempts to address this issue. &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 26 August, 2015, http://timesofindia.indiatimes.com/india/Health-ministry-against-task-force-proposal-to-hike-prices-of-vital-drugs/articleshow/48675930.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;health-ministry-against-task-force-proposal-to-hike-prices-of-vital-drugs-sushmi-dey-4677069&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4677069,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 29015
$metaTitle = &#039;LATEST NEWS UPDATES | Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey&#039;
$metaKeywords = &#039;National Pharmaceutical Pricing Authority (NPPA),Access to Health,Access to Healthcare,Access to Medicines,medicine,Medicine Prices&#039;
$metaDesc = &#039;
-The Times of India

NEW DELHI: A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control,...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics.&lt;br /&gt;&lt;br /&gt;&amp;quot;There is a need to review the implementation of DPCO (Drugs Price Control Order), 2013 to resolve the genuine practical problems of implementation. The government may implement predictable and stable price control mechanisms through consultative approach with the industry,&amp;quot; the taskforce is learnt to have said in its recommendations submitted recently to the health ministry and various government departments including department of pharmaceuticals.&lt;br /&gt;&lt;br /&gt;However, the health ministry is against the revision of the existing price regulation. Though the ministry is yet to evaluate the task force&#039;s recommendations, officials in the ministry said it is unlikely to accept such suggestions. The health ministry, which has always maintained a stand in favour of a stricter price control regime, has also recently set up a separate committee to evaluate the impact of the current price mechanism.&lt;br /&gt;&lt;br /&gt;Top sources in BJP as well as many other government departments also said such recommendations would not be accepted and that there is no question of hiking prices of medicines, mainly the essential ones which are used in treatment of cancer, diabetes and cardiovascular diseases.&lt;br /&gt;&lt;br /&gt;The taskforce, headed by secretary to the department of pharmaceuticals, also included members from the department of industrial policy and promotion (DIPP) under the commerce ministry, Niti Aayog and department of science and technology (DST).&lt;br /&gt;&lt;br /&gt;According to an official source, the panel suggested the government to maintain a balance between affordability of medicines and business viability. &amp;quot;It has also pointed out that over regulation of medicine prices may act as a deterrent for pharmaceutical companies to put in more investment in India and may go against the government&#039;s approach to promote foreign investment,&amp;quot; the official said.&lt;br /&gt;&lt;br /&gt;The recommendations assume significance coming as they do in the wake of a recent report tabled by the pharmaceutical industry highlighting the impact of price control on availability of essential medicines and new drug launches. The industry claimed there is a slowdown in both because of a flawed implementation of the pricing policy by the regulator -National Pharmaceutical Pricing Authority (NPPA).&lt;br /&gt;&lt;br /&gt;The drug pricing policy, approved by the UPA government in 2012, listed 348 essential medicines - prices of which were to be capped at the average of all medicines in a particular therapeutic segment with minimum of 1% market share.&lt;br /&gt;&lt;br /&gt;However, in 2013, when NPPA started implementing the policy, it triggered a lot of resentment among drug manufacturers. Companies complained that the regulator had implemented the policy beyond its purview and included medicines outside the scope of the policy. The industry said NPPA&#039;s move brought in uncertainty for them, thereby delaying new launches.&lt;br /&gt;&lt;br /&gt;However, the regulator has so far maintained that price regulation is done as per DPCO, 2013 and that there was a huge disparity in prices of similar medicines available in the market under different brands, sometimes from the same manufacturer. According to NPPA, the existing price regulation attempts to address this issue. &lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/health-ministry-against-task-force-proposal-to-hike-prices-of-vital-drugs-sushmi-dey-4677069.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Times of India

NEW DELHI: A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control,..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India<br /><br /><em>NEW DELHI: </em>A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics.<br /><br />&quot;There is a need to review the implementation of DPCO (Drugs Price Control Order), 2013 to resolve the genuine practical problems of implementation. The government may implement predictable and stable price control mechanisms through consultative approach with the industry,&quot; the taskforce is learnt to have said in its recommendations submitted recently to the health ministry and various government departments including department of pharmaceuticals.<br /><br />However, the health ministry is against the revision of the existing price regulation. Though the ministry is yet to evaluate the task force's recommendations, officials in the ministry said it is unlikely to accept such suggestions. The health ministry, which has always maintained a stand in favour of a stricter price control regime, has also recently set up a separate committee to evaluate the impact of the current price mechanism.<br /><br />Top sources in BJP as well as many other government departments also said such recommendations would not be accepted and that there is no question of hiking prices of medicines, mainly the essential ones which are used in treatment of cancer, diabetes and cardiovascular diseases.<br /><br />The taskforce, headed by secretary to the department of pharmaceuticals, also included members from the department of industrial policy and promotion (DIPP) under the commerce ministry, Niti Aayog and department of science and technology (DST).<br /><br />According to an official source, the panel suggested the government to maintain a balance between affordability of medicines and business viability. &quot;It has also pointed out that over regulation of medicine prices may act as a deterrent for pharmaceutical companies to put in more investment in India and may go against the government's approach to promote foreign investment,&quot; the official said.<br /><br />The recommendations assume significance coming as they do in the wake of a recent report tabled by the pharmaceutical industry highlighting the impact of price control on availability of essential medicines and new drug launches. The industry claimed there is a slowdown in both because of a flawed implementation of the pricing policy by the regulator -National Pharmaceutical Pricing Authority (NPPA).<br /><br />The drug pricing policy, approved by the UPA government in 2012, listed 348 essential medicines - prices of which were to be capped at the average of all medicines in a particular therapeutic segment with minimum of 1% market share.<br /><br />However, in 2013, when NPPA started implementing the policy, it triggered a lot of resentment among drug manufacturers. Companies complained that the regulator had implemented the policy beyond its purview and included medicines outside the scope of the policy. The industry said NPPA's move brought in uncertainty for them, thereby delaying new launches.<br /><br />However, the regulator has so far maintained that price regulation is done as per DPCO, 2013 and that there was a huge disparity in prices of similar medicines available in the market under different brands, sometimes from the same manufacturer. According to NPPA, the existing price regulation attempts to address this issue. <br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 29015,
		'title' => 'Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey',
		'subheading' => '',
		'description' => '<div align="justify">
-The Times of India<br />
<br />
<em>NEW DELHI: </em>A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics.<br />
<br />
&quot;There is a need to review the implementation of DPCO (Drugs Price Control Order), 2013 to resolve the genuine practical problems of implementation. The government may implement predictable and stable price control mechanisms through consultative approach with the industry,&quot; the taskforce is learnt to have said in its recommendations submitted recently to the health ministry and various government departments including department of pharmaceuticals.<br />
<br />
However, the health ministry is against the revision of the existing price regulation. Though the ministry is yet to evaluate the task force's recommendations, officials in the ministry said it is unlikely to accept such suggestions. The health ministry, which has always maintained a stand in favour of a stricter price control regime, has also recently set up a separate committee to evaluate the impact of the current price mechanism.<br />
<br />
Top sources in BJP as well as many other government departments also said such recommendations would not be accepted and that there is no question of hiking prices of medicines, mainly the essential ones which are used in treatment of cancer, diabetes and cardiovascular diseases.<br />
<br />
The taskforce, headed by secretary to the department of pharmaceuticals, also included members from the department of industrial policy and promotion (DIPP) under the commerce ministry, Niti Aayog and department of science and technology (DST).<br />
<br />
According to an official source, the panel suggested the government to maintain a balance between affordability of medicines and business viability. &quot;It has also pointed out that over regulation of medicine prices may act as a deterrent for pharmaceutical companies to put in more investment in India and may go against the government's approach to promote foreign investment,&quot; the official said.<br />
<br />
The recommendations assume significance coming as they do in the wake of a recent report tabled by the pharmaceutical industry highlighting the impact of price control on availability of essential medicines and new drug launches. The industry claimed there is a slowdown in both because of a flawed implementation of the pricing policy by the regulator -National Pharmaceutical Pricing Authority (NPPA).<br />
<br />
The drug pricing policy, approved by the UPA government in 2012, listed 348 essential medicines - prices of which were to be capped at the average of all medicines in a particular therapeutic segment with minimum of 1% market share.<br />
<br />
However, in 2013, when NPPA started implementing the policy, it triggered a lot of resentment among drug manufacturers. Companies complained that the regulator had implemented the policy beyond its purview and included medicines outside the scope of the policy. The industry said NPPA's move brought in uncertainty for them, thereby delaying new launches.<br />
<br />
However, the regulator has so far maintained that price regulation is done as per DPCO, 2013 and that there was a huge disparity in prices of similar medicines available in the market under different brands, sometimes from the same manufacturer. According to NPPA, the existing price regulation attempts to address this issue. <br />
</div>',
		'credit_writer' => 'The Times of India, 26 August, 2015, http://timesofindia.indiatimes.com/india/Health-ministry-against-task-force-proposal-to-hike-prices-of-vital-drugs/articleshow/48675930.cms',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'health-ministry-against-task-force-proposal-to-hike-prices-of-vital-drugs-sushmi-dey-4677069',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 4677069,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 29015,
	'metaTitle' => 'LATEST NEWS UPDATES | Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey',
	'metaKeywords' => 'National Pharmaceutical Pricing Authority (NPPA),Access to Health,Access to Healthcare,Access to Medicines,medicine,Medicine Prices',
	'metaDesc' => '
-The Times of India

NEW DELHI: A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control,...',
	'disp' => '<div align="justify">-The Times of India<br /><br /><em>NEW DELHI: </em>A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics.<br /><br />&quot;There is a need to review the implementation of DPCO (Drugs Price Control Order), 2013 to resolve the genuine practical problems of implementation. The government may implement predictable and stable price control mechanisms through consultative approach with the industry,&quot; the taskforce is learnt to have said in its recommendations submitted recently to the health ministry and various government departments including department of pharmaceuticals.<br /><br />However, the health ministry is against the revision of the existing price regulation. Though the ministry is yet to evaluate the task force's recommendations, officials in the ministry said it is unlikely to accept such suggestions. The health ministry, which has always maintained a stand in favour of a stricter price control regime, has also recently set up a separate committee to evaluate the impact of the current price mechanism.<br /><br />Top sources in BJP as well as many other government departments also said such recommendations would not be accepted and that there is no question of hiking prices of medicines, mainly the essential ones which are used in treatment of cancer, diabetes and cardiovascular diseases.<br /><br />The taskforce, headed by secretary to the department of pharmaceuticals, also included members from the department of industrial policy and promotion (DIPP) under the commerce ministry, Niti Aayog and department of science and technology (DST).<br /><br />According to an official source, the panel suggested the government to maintain a balance between affordability of medicines and business viability. &quot;It has also pointed out that over regulation of medicine prices may act as a deterrent for pharmaceutical companies to put in more investment in India and may go against the government's approach to promote foreign investment,&quot; the official said.<br /><br />The recommendations assume significance coming as they do in the wake of a recent report tabled by the pharmaceutical industry highlighting the impact of price control on availability of essential medicines and new drug launches. The industry claimed there is a slowdown in both because of a flawed implementation of the pricing policy by the regulator -National Pharmaceutical Pricing Authority (NPPA).<br /><br />The drug pricing policy, approved by the UPA government in 2012, listed 348 essential medicines - prices of which were to be capped at the average of all medicines in a particular therapeutic segment with minimum of 1% market share.<br /><br />However, in 2013, when NPPA started implementing the policy, it triggered a lot of resentment among drug manufacturers. Companies complained that the regulator had implemented the policy beyond its purview and included medicines outside the scope of the policy. The industry said NPPA's move brought in uncertainty for them, thereby delaying new launches.<br /><br />However, the regulator has so far maintained that price regulation is done as per DPCO, 2013 and that there was a huge disparity in prices of similar medicines available in the market under different brands, sometimes from the same manufacturer. According to NPPA, the existing price regulation attempts to address this issue. <br /></div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 29015,
	'title' => 'Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey',
	'subheading' => '',
	'description' => '<div align="justify">
-The Times of India<br />
<br />
<em>NEW DELHI: </em>A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics.<br />
<br />
&quot;There is a need to review the implementation of DPCO (Drugs Price Control Order), 2013 to resolve the genuine practical problems of implementation. The government may implement predictable and stable price control mechanisms through consultative approach with the industry,&quot; the taskforce is learnt to have said in its recommendations submitted recently to the health ministry and various government departments including department of pharmaceuticals.<br />
<br />
However, the health ministry is against the revision of the existing price regulation. Though the ministry is yet to evaluate the task force's recommendations, officials in the ministry said it is unlikely to accept such suggestions. The health ministry, which has always maintained a stand in favour of a stricter price control regime, has also recently set up a separate committee to evaluate the impact of the current price mechanism.<br />
<br />
Top sources in BJP as well as many other government departments also said such recommendations would not be accepted and that there is no question of hiking prices of medicines, mainly the essential ones which are used in treatment of cancer, diabetes and cardiovascular diseases.<br />
<br />
The taskforce, headed by secretary to the department of pharmaceuticals, also included members from the department of industrial policy and promotion (DIPP) under the commerce ministry, Niti Aayog and department of science and technology (DST).<br />
<br />
According to an official source, the panel suggested the government to maintain a balance between affordability of medicines and business viability. &quot;It has also pointed out that over regulation of medicine prices may act as a deterrent for pharmaceutical companies to put in more investment in India and may go against the government's approach to promote foreign investment,&quot; the official said.<br />
<br />
The recommendations assume significance coming as they do in the wake of a recent report tabled by the pharmaceutical industry highlighting the impact of price control on availability of essential medicines and new drug launches. The industry claimed there is a slowdown in both because of a flawed implementation of the pricing policy by the regulator -National Pharmaceutical Pricing Authority (NPPA).<br />
<br />
The drug pricing policy, approved by the UPA government in 2012, listed 348 essential medicines - prices of which were to be capped at the average of all medicines in a particular therapeutic segment with minimum of 1% market share.<br />
<br />
However, in 2013, when NPPA started implementing the policy, it triggered a lot of resentment among drug manufacturers. Companies complained that the regulator had implemented the policy beyond its purview and included medicines outside the scope of the policy. The industry said NPPA's move brought in uncertainty for them, thereby delaying new launches.<br />
<br />
However, the regulator has so far maintained that price regulation is done as per DPCO, 2013 and that there was a huge disparity in prices of similar medicines available in the market under different brands, sometimes from the same manufacturer. According to NPPA, the existing price regulation attempts to address this issue. <br />
</div>',
	'credit_writer' => 'The Times of India, 26 August, 2015, http://timesofindia.indiatimes.com/india/Health-ministry-against-task-force-proposal-to-hike-prices-of-vital-drugs/articleshow/48675930.cms',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'health-ministry-against-task-force-proposal-to-hike-prices-of-vital-drugs-sushmi-dey-4677069',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 4677069,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {},
		(int) 3 => object(Cake\ORM\Entity) {},
		(int) 4 => object(Cake\ORM\Entity) {},
		(int) 5 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 29015
$metaTitle = 'LATEST NEWS UPDATES | Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey'
$metaKeywords = 'National Pharmaceutical Pricing Authority (NPPA),Access to Health,Access to Healthcare,Access to Medicines,medicine,Medicine Prices'
$metaDesc = '
-The Times of India

NEW DELHI: A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control,...'
$disp = '<div align="justify">-The Times of India<br /><br /><em>NEW DELHI: </em>A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics.<br /><br />&quot;There is a need to review the implementation of DPCO (Drugs Price Control Order), 2013 to resolve the genuine practical problems of implementation. The government may implement predictable and stable price control mechanisms through consultative approach with the industry,&quot; the taskforce is learnt to have said in its recommendations submitted recently to the health ministry and various government departments including department of pharmaceuticals.<br /><br />However, the health ministry is against the revision of the existing price regulation. Though the ministry is yet to evaluate the task force's recommendations, officials in the ministry said it is unlikely to accept such suggestions. The health ministry, which has always maintained a stand in favour of a stricter price control regime, has also recently set up a separate committee to evaluate the impact of the current price mechanism.<br /><br />Top sources in BJP as well as many other government departments also said such recommendations would not be accepted and that there is no question of hiking prices of medicines, mainly the essential ones which are used in treatment of cancer, diabetes and cardiovascular diseases.<br /><br />The taskforce, headed by secretary to the department of pharmaceuticals, also included members from the department of industrial policy and promotion (DIPP) under the commerce ministry, Niti Aayog and department of science and technology (DST).<br /><br />According to an official source, the panel suggested the government to maintain a balance between affordability of medicines and business viability. &quot;It has also pointed out that over regulation of medicine prices may act as a deterrent for pharmaceutical companies to put in more investment in India and may go against the government's approach to promote foreign investment,&quot; the official said.<br /><br />The recommendations assume significance coming as they do in the wake of a recent report tabled by the pharmaceutical industry highlighting the impact of price control on availability of essential medicines and new drug launches. The industry claimed there is a slowdown in both because of a flawed implementation of the pricing policy by the regulator -National Pharmaceutical Pricing Authority (NPPA).<br /><br />The drug pricing policy, approved by the UPA government in 2012, listed 348 essential medicines - prices of which were to be capped at the average of all medicines in a particular therapeutic segment with minimum of 1% market share.<br /><br />However, in 2013, when NPPA started implementing the policy, it triggered a lot of resentment among drug manufacturers. Companies complained that the regulator had implemented the policy beyond its purview and included medicines outside the scope of the policy. The industry said NPPA's move brought in uncertainty for them, thereby delaying new launches.<br /><br />However, the regulator has so far maintained that price regulation is done as per DPCO, 2013 and that there was a huge disparity in prices of similar medicines available in the market under different brands, sometimes from the same manufacturer. According to NPPA, the existing price regulation attempts to address this issue. <br /></div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey

-The Times of India NEW DELHI: A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics. "There is a need to review the implementation of DPCO (Drugs Price Control Order), 2013 to resolve the genuine practical problems of implementation. The government may implement predictable and stable price control mechanisms through consultative approach with the industry," the taskforce is learnt to have said in its recommendations submitted recently to the health ministry and various government departments including department of pharmaceuticals. However, the health ministry is against the revision of the existing price regulation. Though the ministry is yet to evaluate the task force's recommendations, officials in the ministry said it is unlikely to accept such suggestions. The health ministry, which has always maintained a stand in favour of a stricter price control regime, has also recently set up a separate committee to evaluate the impact of the current price mechanism. Top sources in BJP as well as many other government departments also said such recommendations would not be accepted and that there is no question of hiking prices of medicines, mainly the essential ones which are used in treatment of cancer, diabetes and cardiovascular diseases. The taskforce, headed by secretary to the department of pharmaceuticals, also included members from the department of industrial policy and promotion (DIPP) under the commerce ministry, Niti Aayog and department of science and technology (DST). According to an official source, the panel suggested the government to maintain a balance between affordability of medicines and business viability. "It has also pointed out that over regulation of medicine prices may act as a deterrent for pharmaceutical companies to put in more investment in India and may go against the government's approach to promote foreign investment," the official said. The recommendations assume significance coming as they do in the wake of a recent report tabled by the pharmaceutical industry highlighting the impact of price control on availability of essential medicines and new drug launches. The industry claimed there is a slowdown in both because of a flawed implementation of the pricing policy by the regulator -National Pharmaceutical Pricing Authority (NPPA). The drug pricing policy, approved by the UPA government in 2012, listed 348 essential medicines - prices of which were to be capped at the average of all medicines in a particular therapeutic segment with minimum of 1% market share. However, in 2013, when NPPA started implementing the policy, it triggered a lot of resentment among drug manufacturers. Companies complained that the regulator had implemented the policy beyond its purview and included medicines outside the scope of the policy. The industry said NPPA's move brought in uncertainty for them, thereby delaying new launches. However, the regulator has so far maintained that price regulation is done as per DPCO, 2013 and that there was a huge disparity in prices of similar medicines available in the market under different brands, sometimes from the same manufacturer. According to NPPA, the existing price regulation attempts to address this issue.